 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 December 1998 | Volume 129 Issue 11 Part 1 | Pages 862-869
Background: Community-acquired bacterial meningitis causes substantial morbidity and mortality in adults.
Objective: To create and test a prognostic model for persons with community-acquired bacterial meningitis and to determine whether antibiotic timing influences clinical outcome.
Design: Retrospective cohort study; patients were divided into derivation and validation samples.
Setting: Four hospitals in Connecticut.
Patients: 269 persons who, between 1970 and 1995, had community-acquired bacterial meningitis microbiologically proven by a lumbar puncture done within 24 hours of presentation in the emergency department.
Measurements: Baseline clinical and laboratory features and times of arrival in the emergency department, performance of lumbar puncture, and administration of antibiotics. The target end point was the development of an adverse clinical outcome (death or neurologic deficit at discharge).
Results: For the total group, the hospital mortality rate was 27%. Fifty-six of 269 patients (21%) developed a neurologic deficit, and in 9% the neurologic deficit persisted at discharge. Three baseline clinical features (hypotension, altered mental status, and seizures) were independently associated with adverse clinical outcome and were used to create a prognostic model from the derivation sample. The prediction accuracy of the model was determined by using the concordance index (c-index). For both the derivation sample (c-index, 0.73 [95% CI, 0.65 to 0.81]) and the validation sample (c-index, 0.81 [CI, 0.71 to 0.92]), the model predicted adverse clinical outcome significantly better than chance. For the total group, the model stratified patients into three prognostic stages: low risk for adverse clinical outcome (9%; stage I), intermediate risk (33%; stage II), and high risk (56%; stage III) (P = 0.001). Adverse clinical outcome was more common for patients in whom the prognostic stage advanced from low risk (P = 0.008) or intermediate risk (P = 0.003) at arrival in the emergency department to high risk before administration of antibiotics.
Conclusions: In persons with community-acquired bacterial meningitis, three baseline clinical features of disease severity predicted adverse clinical outcome and stratified patients into three stages of prognostic severity. Delay in therapy after arrival in the emergency department was associated with adverse clinical outcome when the patient's condition advanced to the highest stage of prognostic severity before the initial antibiotic dose was given.
Author and Article Information
From Waterbury Hospital, Waterbury, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; and Yale University School of Medicine, New Haven, Connecticut.
ARTICLE
Community-Acquired Bacterial Meningitis: Risk Stratification for Adverse Clinical Outcome and Effect of Antibiotic Timing
Acknowledgments: The authors thank Lucy Tomaso and Rita Rossi for manuscript preparation.
Grant Support: In part by Roche Pharmaceuticals. Dr. Quagliarello is supported by the Donaghue Medical Research Foundation.
Requests for Reprints: Vincent Quagliarello, MD, 800 LCI, Yale University School of Medicine, New Haven, CT 06510.
Current Author Addresses: Dr. Aronin: Waterbury Hospital, 64 Robbins Street, Waterbury, CT 06721.
Dr. Peduzzi: Cooperative Studies Program, Veterans Affairs Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516.
Dr. Quagliarello: 800 LCI, Yale University School of Medicine, New Haven, CT 06510.
This article has been cited by other articles:
|
|
 |
|
  A.B. Gjini, J.M. Stuart, K. Cartwright, J. Cohen, M. Jacobs, T. Nichols, N. Ninis, H. Prempeh, A. Whitehouse, and R.S. Heyderman Quality of in-hospital care for adults with acute bacterial meningitis: a national retrospective survey. QJM, November 1, 2006; 99(11): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Drew, K. Kawamoto, and M. B. Adams Information technology for optimizing the management of infectious diseases Am. J. Health Syst. Pharm., May 15, 2006; 63(10): 957 - 965. [Full Text] [PDF]
|
|
|
|
 |
|
 D. van de Beek, J. de Gans, A. R. Tunkel, and E. F.M. Wijdicks Community-Acquired Bacterial Meningitis in Adults N. Engl. J. Med., January 5, 2006; 354(1): 44 - 53. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Srivastava, P. Henneke, A. Visintin, S. C. Morse, V. Martin, C. Watkins, J. C. Paton, M. R. Wessels, D. T. Golenbock, and R. Malley The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease Infect. Immun., October 1, 2005; 73(10): 6479 - 6487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hara and S. Stone Antibiotics for Life-Threatening Illness Journal of Pharmacy Practice, October 1, 2005; 18(5): 336 - 350. [Abstract] [PDF]
|
|
|
|
|
|
N. Proulx, D. Frechette, B. Toye, J. Chan, and S. Kravcik Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis QJM, April 1, 2005; 98(4): 291 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Lewin III, M. Lapointe, and W. C. Ziai Central Nervous System Infections in the Critically Ill Journal of Pharmacy Practice, February 1, 2005; 18(1): 25 - 41. [Abstract] [PDF]
|
|
|
|
 |
|
 R F M Chin, B G R Neville, and R C Scott Meningitis is a common cause of convulsive status epilepticus with fever Arch. Dis. Child., January 1, 2005; 90(1): 66 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. van de Beek, J. de Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis N. Engl. J. Med., October 28, 2004; 351(18): 1849 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Fowler Jr, M. K. Olsen, G. R. Corey, C. W. Woods, C. H. Cabell, L. B. Reller, A. C. Cheng, T. Dudley, and E. Z. Oddone Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia Arch Intern Med, September 22, 2003; 163(17): 2066 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tabas, H. F. Chambers, D. N. Tancredi, W. D. Binder, V. Abril, E. Ortega, A. R. Joffe, M. Poshkus, S. Obaro, J. de Gans, et al. Dexamethasone in Adults with Bacterial Meningitis N. Engl. J. Med., March 6, 2003; 348(10): 954 - 957. [Full Text] [PDF]
|
|
|
|
|
|
J. de Gans, D. van de Beek, and the European Dexamethasone in Adulthood Bacterial Dexamethasone in Adults with Bacterial Meningitis N. Engl. J. Med., November 14, 2002; 347(20): 1549 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.R. CHADWICK and A.M.L. LEVER The impact of new diagnostic methodologies in the management of meningitis in adults at a teaching hospital QJM, October 1, 2002; 95(10): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Johnson Delayed Treatment of Bacterial Meningitis Ann Intern Med, November 2, 1999; 131(9): 715 - 715. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Attia, R. Hatala, D. J. Cook, and J. G. Wong Does This Adult Patient Have Acute Meningitis? JAMA, July 14, 1999; 282(2): 175 - 181. [Abstract] [Full Text] [PDF]
|
|
Article
